Mangrove Partners’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-945,417
| Closed | -$8.45M | – | 189 |
|
|
2023
Q3 | $8.45M | Buy |
+945,417
| New | +$8.45M | 0.64% | 57 |
|
|
2022
Q2 | – | Sell |
-652,372
| Closed | -$16.8M | – | 531 |
|
|
2022
Q1 | $16.8M | Hold |
652,372
| – | – | 0.91% | 9 |
|
|
2021
Q4 | $20.3M | Hold |
652,372
| – | – | 1.2% | 4 |
|
|
2021
Q3 | $15.8M | Buy |
652,372
+357,335
| +121% | +$8.67M | 1.42% | 6 |
|
|
2021
Q2 | $4.31M | Buy |
+295,037
| New | +$4.31M | 0.44% | 51 |
|